Advancing Chronic Intrathecal Delivery via Implantable Port-Catheter Systems to Improve CNS Therapeutic Access & Patient Experience

• Introducing the design and functionality of implantable intrathecal port‑catheter systems enabling repeat access to cerebrospinal fluid for CNS therapeutic delivery
• Evaluating how device-enabled delivery can reduce reliance on repeated lumbar punctures and improve patient experience adherence and long-term feasibility
• Sharing clinical progress and learnings from ongoing studies assessing safety performance and real-world usability of implantable intrathecal delivery platforms
• Exploring the future role of integrated drug-device solutions in scaling antisense oligonucleotide and advanced therapy delivery across CNS indications

Speakers:

Janelle Arrambide

Head of Device Clinical

Biogen

Andrew East

Head of IDU Device Development & Manufacturing

Biogen